Eiger BioPharmaceuticals, Inc. (EIGR)
NASDAQ: EIGR · IEX Real-Time Price · USD
5.01
+0.04 (0.70%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Eiger BioPharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 2011
Revenue
13.4812.1400000000
Upgrade
Revenue Growth (YoY)
11.05%---------
Upgrade
Cost of Revenue
1.840.7500000000
Upgrade
Gross Profit
11.6511.400000000
Upgrade
Selling, General & Admin
29.1123.920.5617.1113.961213.114.860.873.04
Upgrade
Research & Development
75.2864.4441.5951.7937.0929.5233.018.120.6416.93
Upgrade
Operating Expenses
104.3988.3462.1568.951.0541.5246.1212.971.5219.96
Upgrade
Operating Income
-92.74-76.94-62.15-68.9-51.05-41.52-46.12-12.97-1.52-19.96
Upgrade
Interest Expense / Income
4.133.563.593.412.331.520.690.3500.06
Upgrade
Other Expense / Income
-0.12-46.65-0.69-2.06-0.99-0.60.28---0.03
Upgrade
Pretax Income
-96.75-33.85-65.05-70.25-52.39-42.45-47.09-13.32-1.52-20
Upgrade
Income Tax
0.020.0600000000
Upgrade
Net Income
-96.78-33.92-65.05-70.25-52.39-42.45-47.09-13.32-1.52-20
Upgrade
Preferred Dividends
0000000000.86
Upgrade
Net Income Common
-96.78-33.92-65.05-70.25-52.39-42.45-47.09-13.32-1.52-23.96
Upgrade
Shares Outstanding (Basic)
1111000000
Upgrade
Shares Outstanding (Diluted)
1111000000
Upgrade
Shares Change
22.64%20.61%23.51%67.12%56.21%45.30%2704.01%10.51%228.85%7.55%
Upgrade
EPS (Basic)
-69.60-30.00-69.30-92.40-115.20-145.80-235.20-1865.70-234.60-12192.30
Upgrade
EPS (Diluted)
-69.60-30.00-69.30-92.40-115.20-145.80-235.20-1865.70-234.60-12192.30
Upgrade
Free Cash Flow
-83.35-71.29-63.44-64.09-42.81-38.42-38.03-9.18-1.28-16.28
Upgrade
Free Cash Flow Per Share
-60.07-63.00-67.63-84.38-94.20-132.04-189.92-1285.41-198.56-8287.22
Upgrade
Gross Margin
86.38%93.86%--------
Upgrade
Operating Margin
-687.78%-633.66%--------
Upgrade
Profit Margin
-717.71%-279.34%--------
Upgrade
Free Cash Flow Margin
-618.14%-587.10%--------
Upgrade
EBITDA
-91.78-29.5-60.81-66.36-50.01-40.88-46.37-12.96-1.51-19.87
Upgrade
EBITDA Margin
-680.65%-242.92%--------
Upgrade
Depreciation & Amortization
0.840.80.650.490.050.040.020.010.010.07
Upgrade
EBIT
-92.62-30.29-61.46-66.85-50.06-40.92-46.4-12.97-1.52-19.94
Upgrade
EBIT Margin
-686.90%-249.50%--------
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).